DrugInfoSys

L-Ornithine L-Aspartate

Drug #907

L-Ornithine L-Aspartate is a hepato (liver) protective. L-Ornithine L-Aspartate is used in the treatment of jaundice, acute hepatitis.

Primary Characteristics

It is classified in Hepatoprotective, Lipotropic pharmacological group.

Solubility in Water: null · Solubility in Alcohol: null · Non-proprietary name: L-Ornithine L-Aspartate.

Molecular structure of L-Ornithine L-Aspartate

Pharmacokinetics

None recorded.

Advertisement

Indications

L-Ornithine L-Aspartate is primarily indicated in conditions like Hepatic encephalopathy, Hepatitis, Jaundice, Liver cirrhosis.

L-Ornithine L-Aspartate is also indicated for secondary conditions like Tuberculosis.

Contraindications

L-Ornithine L-Aspartate is contraindicated in conditions like Renal insufficiency, Pregnancy.

Dosage

L-Ornithine L-Aspartate's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
300 mg300 mgEvery 12hIVFor 3-4 Weeks
600 mg600 mgEvery 12hPO
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

L-Ornithine L-Aspartate is known to cause more or less tolerable side effects which are usually transient. These include Transient nausea and vomiting.

Warnings / Precautions

In patient with severe renal insufficiency blood urea, and serum creatinine must be monitored regularly, serum creartinine value exceeding 3gm/ml is regarded as reference value.

Available Brands

Click on a strength to view available brands.

Storage Conditions

L-Ornithine L-Aspartate should be stored .

Drug Classification

  1. 1.17.9Cholagogues & hepatic preparations

Manufacturers